Optical imaging developer VisEn Medical of Bedford, MA, has launched its new GastroSense 750 fluorescence agent for in vivo imaging of gastric motility and related drug effects.
GastroSense 750 is designed for real-time quantitative measurements of gastric motility in animal models, thereby enabling assessment of a variety of related diseases and drug effects in preclinical research and drug development.
Related Reading
VisEn rolls out VivoTag, March 12, 2010
VisEn buys rights to fluorescence agents, January 28, 2010
VisEn launches imaging agent, January 19, 2010
VisEn debuts new molecular imaging agents, November 20, 2009
VisEn debuts molecular agent, FMT systems, September 24, 2009
Copyright © 2010 AuntMinnie.com